Trial Profile
A Study on The Effect of Hepatic Impairment on The Pharmacokinetics of RO4917838
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Bitopertin (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Roche
- 09 Aug 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
- 15 Jun 2011 Planned end date (1 Nov 2011) added as reported by ClinicalTrials.gov.
- 15 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.